The Penn Medicine Princeton Cancer Center in Plainsboro has received a $2.5 million grant from the Bristol Myers Squibb Foundation to help fund a new program
For decades, racial and ethnic minorities have been underrepresented in clinical trials even though they are disproportionately affected by several health issues such as diabetes and hypertension.
Amgen Joins Gilead Sciences as a Program SupporterApplications Now Open for Physicians and Medical StudentsOriginally published on Bristol Myers Squibb News & PerspectivesPRINCETON, NJ / ACCESSWIRE / January